Sollus Therapeutics, Inc.
Biotechnology company · Chapel Hill, North Carolina, United States
Sollus Therapeutics, Inc. is a biotechnology company headquartered in Chapel Hill, North Carolina, United States. It has received 2 NIH small-business research grants, $696,028 in total.
Profile compiled from public records. Is this your company? Request a correction or update
Sollus Therapeutics at a glance
Typebiotechnology company
HeadquartersChapel Hill, North Carolina, United States
What does Sollus Therapeutics do?
US government research funding
2 NIH small-business research grants, $696,028 in total. NIH funding came from the National Cancer Institute, National Center for Advancing Translational Sciences.
Frequently asked questions about Sollus Therapeutics
Where is Sollus Therapeutics headquartered?
Sollus Therapeutics, Inc. is headquartered in Chapel Hill, North Carolina, United States.
What does Sollus Therapeutics do?
Sollus Therapeutics, Inc. is a biotechnology company.
Similar companies
- BioKier, Inc.Chapel Hill, North Carolina, United States
- Redbud Labs, Inc.Chapel Hill, North Carolina, United States
- Clinical Tools, IncChapel Hill, North Carolina, United States
- OncoTrap, Inc.Chapel Hill, North Carolina, United States
- Areteia Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Vascular Pharmaceuticals, Inc.Chapel Hill, North Carolina, United States
- Falcon Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Chaperone Therapeutics, Inc.Chapel Hill, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences